Acutis Biosciences needed an identity and an investor narrative that could raise money and open partnership conversations at the same time. I designed the site, pitch materials, and full visual system, and separated the subsidiary from its parent brand without losing the credibility that connection brought. Design as business development.
CLIENT ▸ Acutis Biosciences, NJ, USA
YEAR ▸ 2021 - 2023
AREA ▸ Oncology — Precision Medicine (pre-commercial biotech)
AUDIENCE ▸ Investor, Strategic Partner, Scientific Community
SCOPE ▸ Identity system, investor narrative, brand architecture
SCALE ▸ 2 brands separated (parent and subsidiary), 24-page pitch deck, 12 templates, 24-month engagement
ROLE ▸ Brand Lead
TEAM ▸ Led 2: 1 copywriter, 1 medical writer. Worked directly with the CEO
PROCESS ▸ Positioning and brand architecture → identity system → investor narrative and pitch framework → templates and rollout
YEAR ▸ 2021 - 2023
AREA ▸ Oncology — Precision Medicine (pre-commercial biotech)
AUDIENCE ▸ Investor, Strategic Partner, Scientific Community
SCOPE ▸ Identity system, investor narrative, brand architecture
SCALE ▸ 2 brands separated (parent and subsidiary), 24-page pitch deck, 12 templates, 24-month engagement
ROLE ▸ Brand Lead
TEAM ▸ Led 2: 1 copywriter, 1 medical writer. Worked directly with the CEO
PROCESS ▸ Positioning and brand architecture → identity system → investor narrative and pitch framework → templates and rollout
The Challenge
• Launch a biotech brand with immediate credibility, distinct from,
but connected to, Acutis Diagnostics
• Translate complex science into a clear identity that reads as rigorous,
modern, and investable
• Build a scalable system that works across digital, decks, lab materials,
and partner communications
• Launch a biotech brand with immediate credibility, distinct from,
but connected to, Acutis Diagnostics
• Translate complex science into a clear identity that reads as rigorous,
modern, and investable
• Build a scalable system that works across digital, decks, lab materials,
and partner communications
Strategic Approach
• Define positioning around scientific precision + translational impact
(research → real-world application)
• Create clear separation of brand roles: parent vs. biosciences entity
• Build an identity architecture designed to scale across future pipelines,
programs, and audiences
• Define positioning around scientific precision + translational impact
(research → real-world application)
• Create clear separation of brand roles: parent vs. biosciences entity
• Build an identity architecture designed to scale across future pipelines,
programs, and audiences
Creative Solution
• A clean, high-authority biotech identity anchored in typographic clarity
and disciplined structure
• A visual language that signals research depth without falling
into generic “molecule” clichés
• A system that balances scientific seriousness with modern brand presence
• A clean, high-authority biotech identity anchored in typographic clarity
and disciplined structure
• A visual language that signals research depth without falling
into generic “molecule” clichés
• A system that balances scientific seriousness with modern brand presence
Scope & System
• Core identity architecture: mark, wordmark, typography, and color logic
• Grid + hierarchy rules for biotech communications
(decks, one-pagers, data-forward layouts)
• Modular components for fast production without losing consistency
• Application framework for digital and presentation environments
• Core identity architecture: mark, wordmark, typography, and color logic
• Grid + hierarchy rules for biotech communications
(decks, one-pagers, data-forward layouts)
• Modular components for fast production without losing consistency
• Application framework for digital and presentation environments
Deliverables
+ Logo/wordmark system
+ Core visual identity guidelines
+ Pitch/corporate deck framework
+ Digital and print brand assets
+ Template components for scientific and marketing communications
+ Logo/wordmark system
+ Core visual identity guidelines
+ Pitch/corporate deck framework
+ Digital and print brand assets
+ Template components for scientific and marketing communications
Role & Leadership
▸ Brand Lead, from positioning through rollout,
working directly with the CEO.
Led a copywriter and a medical writer, so the science was translated accurately rather than decorated.
Owned the hardest structural call: separating the subsidiary from the parent without severing the credibility link between them.
▸ Brand Lead, from positioning through rollout,
working directly with the CEO.
Led a copywriter and a medical writer, so the science was translated accurately rather than decorated.
Owned the hardest structural call: separating the subsidiary from the parent without severing the credibility link between them.
On The Work
▸ Biotech brands don’t earn trust through aesthetics.
They earn it through clarity, rigor, and consistency.
This identity was designed to help Acutis Biosciences communicate complex science with confidence, align stakeholders quickly, and build long-term credibility across investors, partners, and scientific audiences as the pipeline evolves.
▸ Biotech brands don’t earn trust through aesthetics.
They earn it through clarity, rigor, and consistency.
This identity was designed to help Acutis Biosciences communicate complex science with confidence, align stakeholders quickly, and build long-term credibility across investors, partners, and scientific audiences as the pipeline evolves.
Logo and identity: Logotype extending the Acutis Diagnostics mark, keeping the family link
↓
↓
The logo extends the Acutis Diagnostics logotype, ensuring visual continuity
and clearly positioning Biosciences within the Acutis brand family.
and clearly positioning Biosciences within the Acutis brand family.
Pitch deck: 24-page investor deck framework
↓
↓
Digital: Website and digital brand assets
↓
↓
Image direction: Circular image frames pairing cell imagery, lab environments, and genomic data
↓
↓
Social: Post templates built on the brand grid, palette, and typography
↓
↓
↑
Print: One-pagers and print assets
↓
Print: One-pagers and print assets
↓
Looking to launch or scale your biotech brand with clarity and credibility?